Cargando…

Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review

S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and...

Descripción completa

Detalles Bibliográficos
Autores principales: Jing, Jia, Rui, Li, Junyuan, Sun, Jinfeng, Yang, Zhihao, Hong, Weiguo, Lu, Zhenyu, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113621/
https://www.ncbi.nlm.nih.gov/pubmed/37089937
http://dx.doi.org/10.3389/fphar.2023.1122008
_version_ 1785027879928594432
author Jing, Jia
Rui, Li
Junyuan, Sun
Jinfeng, Yang
Zhihao, Hong
Weiguo, Lu
Zhenyu, Jia
author_facet Jing, Jia
Rui, Li
Junyuan, Sun
Jinfeng, Yang
Zhihao, Hong
Weiguo, Lu
Zhenyu, Jia
author_sort Jing, Jia
collection PubMed
description S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and numerous Skp2 inhibiting compounds have been identified. In this review, we would describe the structural features of Skp2, introduce the ubiquitination function of SCF(Skp2), and summarize the diverse natural and synthetic Skp2 inhibiting compounds reported to date. The IC(50) data of the Skp2 inhibitors or inhibiting compounds in various kinds of tumors at cellular levels implied that the cancer type, stage and pathological mechanisms should be taken into consideration when selecting Skp2-inhibiting compound for cancer treatment.
format Online
Article
Text
id pubmed-10113621
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101136212023-04-20 Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review Jing, Jia Rui, Li Junyuan, Sun Jinfeng, Yang Zhihao, Hong Weiguo, Lu Zhenyu, Jia Front Pharmacol Pharmacology S-phase kinase-associated protein 2 (Skp2) is a substrate-specific adaptor in Skp1-CUL1-ROC1-F-box E3 ubiquitin ligases and widely regarded as an oncogene. Therefore, Skp2 has remained as an active anticancer research topic since its discovery. Accordingly, the structure of Skp2 has been solved and numerous Skp2 inhibiting compounds have been identified. In this review, we would describe the structural features of Skp2, introduce the ubiquitination function of SCF(Skp2), and summarize the diverse natural and synthetic Skp2 inhibiting compounds reported to date. The IC(50) data of the Skp2 inhibitors or inhibiting compounds in various kinds of tumors at cellular levels implied that the cancer type, stage and pathological mechanisms should be taken into consideration when selecting Skp2-inhibiting compound for cancer treatment. Frontiers Media S.A. 2023-04-05 /pmc/articles/PMC10113621/ /pubmed/37089937 http://dx.doi.org/10.3389/fphar.2023.1122008 Text en Copyright © 2023 Jing, Rui, Junyuan, Jinfeng, Zhihao, Weiguo and Zhenyu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Jing, Jia
Rui, Li
Junyuan, Sun
Jinfeng, Yang
Zhihao, Hong
Weiguo, Lu
Zhenyu, Jia
Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
title Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
title_full Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
title_fullStr Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
title_full_unstemmed Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
title_short Small-molecule compounds inhibiting S-phase kinase-associated protein 2: A review
title_sort small-molecule compounds inhibiting s-phase kinase-associated protein 2: a review
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113621/
https://www.ncbi.nlm.nih.gov/pubmed/37089937
http://dx.doi.org/10.3389/fphar.2023.1122008
work_keys_str_mv AT jingjia smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview
AT ruili smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview
AT junyuansun smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview
AT jinfengyang smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview
AT zhihaohong smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview
AT weiguolu smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview
AT zhenyujia smallmoleculecompoundsinhibitingsphasekinaseassociatedprotein2areview